Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding-Shinn Chen

Showing results (31-40 of 332) with videos related to

Pageof 34
Sort By:
Hepatology (Baltimore, Md.)|June 1, 2007
APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answersTung-Hung Su, Jia-Horng Kao, Ding-Shinn Chen
Hepatology (Baltimore, Md.)|July 9, 2004
A forgotten population with chronic hepatitis C infection: subjects coinfected with hepatitis B virusChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen
Hepatology International|August 12, 2009
Dual chronic hepatitis B virus and hepatitis C virus infectionChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen
Journal of Hepatology|February 7, 2002
Hepatitis B viral genotypes and lamivudine resistanceJia-Horng Kao, Chun-Jen Liu, Ding-Shinn Chen
Journal of Biomedical Science|February 18, 2004
Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: mechanisms for the superior antitumor activity of live tumor cell vaccinesKuo-Feng Tai, Ding-Shinn Chen, Lih-Hwa Hwang
Expert Opinion on Biological Therapy|April 18, 2014
Peginterferon α in the treatment of chronic hepatitis BTai-Chung Tseng, Jia-Horng Kao, Ding-Shinn Chen
Journal of Hepatology|April 29, 2015
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsStephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 13, 2006
Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NATChun-Jen Liu, Ding-Shinn Chen, Pei-Jer Chen
The New England Journal of Medicine|October 20, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCVChen-Hua Liu, Ding-Shinn Chen, Jia-Horng Kao
Advances in Cancer Research|November 2, 2010
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspectsJia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen
Pageof 34

Showing results (31-40 of 332) with videos related to

Sort By:
Pageof 34
Hepatology (Baltimore, Md.)|June 1, 2007
APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answersTung-Hung Su, Jia-Horng Kao, Ding-Shinn Chen
Hepatology (Baltimore, Md.)|July 9, 2004
A forgotten population with chronic hepatitis C infection: subjects coinfected with hepatitis B virusChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen
Hepatology International|August 12, 2009
Dual chronic hepatitis B virus and hepatitis C virus infectionChun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen
Journal of Hepatology|February 7, 2002
Hepatitis B viral genotypes and lamivudine resistanceJia-Horng Kao, Chun-Jen Liu, Ding-Shinn Chen
Journal of Biomedical Science|February 18, 2004
Curative potential of GM-CSF-secreting tumor cell vaccines on established orthotopic liver tumors: mechanisms for the superior antitumor activity of live tumor cell vaccinesKuo-Feng Tai, Ding-Shinn Chen, Lih-Hwa Hwang
Expert Opinion on Biological Therapy|April 18, 2014
Peginterferon α in the treatment of chronic hepatitis BTai-Chung Tseng, Jia-Horng Kao, Ding-Shinn Chen
Journal of Hepatology|April 29, 2015
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsStephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 13, 2006
Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NATChun-Jen Liu, Ding-Shinn Chen, Pei-Jer Chen
The New England Journal of Medicine|October 20, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCVChen-Hua Liu, Ding-Shinn Chen, Jia-Horng Kao
Advances in Cancer Research|November 2, 2010
Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspectsJia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen
Pageof 34